Literature DB >> 1371864

Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase H using chimeric methylphosphonodiester/phosphodiester structures.

R V Giles1, D M Tidd.   

Abstract

One of the inherent problems in the use of antisense oligodeoxynucleotides to ablate gene expression in cell cultures is that the stringency of hybridization in vivo is not subject to control and may be sub-optimal. Consequently, phosphodiester or phosphorothioate antisense effectors and non-targeted cellular RNA may form partial hybrids which are substrates for RNase H. Such processes could promote the sequence dependent inappropriate effects recently reported in the literature. We have attempted to resolve this problem by using chimeric methylphosphonodiester/phosphodiester oligodeoxynucleotides. In contrast to the extensive RNA degradation observed with all-phosphodiester oligodeoxynucleotides, highly modified chimeric antisense effectors displayed negligible, or undetectable, cleavage at non-target sites without significantly impaired activity at the target site. We also note that all of the all-phosphodiester oligodeoxynucleotides tested demonstrated inappropriate effects, and that such undesirable activity could vary widely between different sequences.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371864      PMCID: PMC312015          DOI: 10.1093/nar/20.4.763

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  26 in total

1.  Antisense inhibition of ras p21 expression that is sensitive to a point mutation.

Authors:  E H Chang; P S Miller; C Cushman; K Devadas; K F Pirollo; P O Ts'o; Z P Yu
Journal:  Biochemistry       Date:  1991-08-27       Impact factor: 3.162

2.  Antisense oligodeoxyribonucleotide-directed cleavage of maternal mRNA in Xenopus oocytes and embryos.

Authors:  J Shuttleworth; G Matthews; L Dale; C Baker; A Colman
Journal:  Gene       Date:  1988-12-10       Impact factor: 3.688

3.  An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation.

Authors:  J T Holt; R L Redner; A W Nienhuis
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

4.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

Review 5.  A new approach to chemotherapy based on molecular biology and nucleic acid chemistry: Matagen (masking tape for gene expression).

Authors:  P S Miller; P O Ts'o
Journal:  Anticancer Drug Des       Date:  1987-10

6.  Induction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphonate oligodeoxynucleoside targeted to a U3 enhancer element.

Authors:  J Laurence; S K Sikder; J Kulkosky; P Miller; P O Ts'o
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

7.  Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16.

Authors:  A Storey; D Oates; L Banks; L Crawford; T Crook
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

8.  Physicochemical properties of phosphorothioate oligodeoxynucleotides.

Authors:  C A Stein; C Subasinghe; K Shinozuka; J S Cohen
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

9.  Nucleotide sequence of cloned cDNA of human c-myc oncogene.

Authors:  R Watt; L W Stanton; K B Marcu; R C Gallo; C M Croce; G Rovera
Journal:  Nature       Date:  1983 Jun 23-29       Impact factor: 49.962

10.  Nonspecific effects of oligodeoxynucleotide injection in Xenopus oocytes: a reevaluation of previous D7 mRNA ablation experiments.

Authors:  R C Smith; W M Bement; M A Dersch; E Dworkin-Rastl; M B Dworkin; D G Capco
Journal:  Development       Date:  1990-11       Impact factor: 6.868

View more
  27 in total

1.  Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences.

Authors:  Gunter Kraus; Rebeca Geffin; Gina Spruill; Andrea K Young; Rachel Seivright; Diana Cardona; Jennifer Burzawa; H James Hnatyszyn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  Oligodeoxynucleoside phosphoramidates (P-NH2): synthesis and thermal stability of duplexes with DNA and RNA targets.

Authors:  S Peyrottes; J J Vasseur; J L Imbach; B Rayner
Journal:  Nucleic Acids Res       Date:  1996-05-15       Impact factor: 16.971

3.  Intra-amygdala injections of CREB antisense impair inhibitory avoidance memory: role of norepinephrine and acetylcholine.

Authors:  Clinton E Canal; Qing Chang; Paul E Gold
Journal:  Learn Mem       Date:  2008-08-26       Impact factor: 2.460

4.  A rapid in vitro method for obtaining RNA accessibility patterns for complementary DNA probes: correlation with an intracellular pattern and known RNA structures.

Authors:  O Matveeva; B Felden; S Audlin; R F Gesteland; J F Atkins
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

5.  Selective inhibition of cell-free translation by oligonucleotides targeted to a mRNA hairpin structure.

Authors:  R Le Tinévez; R K Mishra; J J Toulmé
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

6.  Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.

Authors:  S Gryaznov; T Skorski; C Cucco; M Nieborowska-Skorska; C Y Chiu; D Lloyd; J K Chen; M Koziolkiewicz; B Calabretta
Journal:  Nucleic Acids Res       Date:  1996-04-15       Impact factor: 16.971

7.  Single base discrimination for ribonuclease H-dependent antisense effects within intact human leukaemia cells.

Authors:  R V Giles; C J Ruddell; D G Spiller; J A Green; D M Tidd
Journal:  Nucleic Acids Res       Date:  1995-03-25       Impact factor: 16.971

8.  Structural basis for the RNA binding selectivity of oligonucleotide analogues containing alkylsulfide internucleoside linkages and 2'-substituted 3'-deoxyribonucleosides.

Authors:  M J Damha; B Meng; D Wang; C G Yannopoulos; G Just
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

9.  A more efficient and specific strategy in the ablation of mRNA in Xenopus laevis using mixtures of antisense oligos.

Authors:  R Morgan; M Edge; A Colman
Journal:  Nucleic Acids Res       Date:  1993-09-25       Impact factor: 16.971

10.  Antisense oligodeoxynucleotides: synthesis, biophysical and biological evaluation of oligodeoxynucleotides containing modified pyrimidines.

Authors:  Y S Sanghvi; G D Hoke; S M Freier; M C Zounes; C Gonzalez; L Cummins; H Sasmor; P D Cook
Journal:  Nucleic Acids Res       Date:  1993-07-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.